Fundraising Fox
Organo-ID
Founded 2020 · 7 employees on LinkedIn · 1 known investors
Find your way into Organo-ID
Sign up to see every warm intro you have to Organo-ID
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Organo-ID team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Organo-ID develops iPSC-derived organoid systems, including 3D hepatocyte models, to test drugs in better-modeled biological systems for predictive diagnostics and personalized therapies. The company serves drug development and treatment applications in oncology and rare disease, operating from Turkey with a global focus.
Founders & leadership
Organo-ID was founded in 2020 by Prof. Dr. Erdal, Bugraer Aslan, and Esra Erdal.
Investors · 1
Frequently asked questions
- What does Organo-ID do?
- Organo-ID develops iPSC-derived organoid systems, including 3D hepatocyte models, to test drugs in better-modeled biological systems for predictive diagnostics and personalized therapies. The company serves drug development and treatment applications in oncology and rare disease, operating from Turkey with a global focus.
- Who founded Organo-ID?
- Organo-ID was founded by Prof. Dr. Erdal, Bugraer Aslan, Esra Erdal in 2020.
- Who are Organo-ID's investors?
- Organo-ID's investors include Idacapital.